MYO1D expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.02882155520001E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.8977000494973E-09 |
Normal-vs-Stage2 |
7.64589946911087E-10 |
Normal-vs-Stage3 |
7.18980430747251E-13 |
Normal-vs-Stage4 |
1.62547753035369E-12 |
Stage1-vs-Stage2 |
5.029800E-02 |
Stage1-vs-Stage3 |
1.026460E-02 |
Stage1-vs-Stage4 |
2.47289999999456E-05 |
Stage2-vs-Stage3 |
8.139800E-01 |
Stage2-vs-Stage4 |
2.150000E-01 |
Stage3-vs-Stage4 |
7.289700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63302704692114E-12 |
Normal-vs-AfricanAmerican |
8.477300E-03 |
Normal-vs-Asian |
1.159210E-01 |
Caucasian-vs-AfricanAmerican |
7.481700E-02 |
Caucasian-vs-Asian |
2.298400E-01 |
AfricanAmerican-vs-Asian |
9.230400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.25639515352805E-11 |
Normal-vs-Female |
2.1538326677728E-13 |
Male-vs-Female |
7.723600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.383400E-03 |
Normal-vs-Age(41-60Yrs) |
2.98950000310327E-08 |
Normal-vs-Age(61-80Yrs) |
1.63702384980979E-12 |
Normal-vs-Age(81-100Yrs) |
5.26690024926779E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.500800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.917500E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.883200E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.985300E-04 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.702800E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.160210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.283930E-02 |
Normal-vs-Grade 2 |
2.12410000699492E-09 |
Normal-vs-Grade 3 |
2.01361149976265E-12 |
Normal-vs-Grade 4 |
2.20801155137451E-12 |
Grade 1-vs-Grade 2 |
5.969800E-01 |
Grade 1-vs-Grade 3 |
1.676960E-01 |
Grade 1-vs-Grade 4 |
4.921600E-02 |
Grade 2-vs-Grade 3 |
3.204200E-02 |
Grade 2-vs-Grade 4 |
6.263800E-03 |
Grade 3-vs-Grade 4 |
3.105600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62436730732907E-12 |
Normal-vs-ccB subtype |
5.80550000000013E-05 |
ccA subtype-vs-ccB subtype |
3.54680000036467E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.17510462366499E-11 |
Normal-vs-N1 |
1.95692999999109E-05 |
N0-vs-N1 |
5.478000E-01 |
|
|